ALLO vs QS · rev $22.0K vs $5.16B cap
Allogene Therapeutics Inc (ALLO) versus Quantumscape Corp (QS) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Quantumscape Corp (QS) is a auto parts company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
QS does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. QS currently screens at market cap $5.16B.
Not investment advice. Open the ALLO and QS stock pages for the full models.
Not investment advice.